Physiotherapy Interventions for Migraine: A Systematic Review of Clinical Trials.
- 1Faculty of Health Sciences with the Institute of Maritime and Tropical Medicine, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
- 2Department of Public Health & Social Medicine, Faculty of Health Sciences with the Institute of Maritime and Tropical Medicine, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Abstract
Background: Migraine is one of the leading causes of disability worldwide and significantly reduces quality of life. Standard pharmacological treatment is often associated with adverse effects and does not always provide satisfactory long-term outcomes. Consequently, increasing attention has been directed toward non-pharmacological interventions such as physiotherapy. The aim of this systematic review was to evaluate the effectiveness of physiotherapy used as a standalone or complementary treatment for migraine. Methods: A systematic review of randomized controlled trials (RCTs) published between 2015 and 2025 was conducted in accordance with PRISMA 2020 guidelines. Electronic databases (PubMed, Cochrane Library, Scopus and PEDro) were searched using predefined search strategies. Studies involving adults diagnosed with migraine who received physiotherapy interventions (e.g., manual therapy, exercise therapy) were included. Two reviewers independently screened records and extracted data. Methodological quality of included studies was assessed using the PEDro scale. Results: Thirteen clinical trials (including 12 RCTs) involving 1021 participants were included. The most frequently investigated interventions were manual therapy and exercise therapy. Improvements in at least one primary clinical outcome (migraine frequency, pain intensity, or disability scores such as MIDAS or HIT-6) were observed in 8 out of 13 studies. A reduction in migraine frequency was reported in 4 studies. However, results were inconsistent across trials, and several studies found no statistically significant differences between the intervention and control groups. Conclusions: Physiotherapy may represent a beneficial complementary approach in migraine management, particularly for improving pain intensity and disability outcomes. However, the available evidence is limited by significant heterogeneity in intervention protocols, outcome measures, and follow-up duration, as well as the lack of quantitative synthesis. Further high-quality randomized trials with standardized methodology and longer follow-up periods are required to strengthen the evidence base.
Related
- Core outcome sets developed for research relevant to physiotherapy interventions: a systematic review
- Clinical Phenotypes, Neuroimaging, and Outcomes in Prolonged and Persistent Non-Motor Migraine Aura: A Systematic Review and Episode-Level Synthesis
- Therapeutic Interventions in Niemann–Pick Disease Type C: A Systematic Review of Clinical Outcomes and Safety
- Digital, Mobile and Artificial Intelligence‐Supported Interventions for Pressure Injury Prevention and Management: A Systematic Review of Clinical, Workflow and Implementation Outcomes
- Effects of collaborative clinical visit agenda-setting interventions: A systematic review and meta-analysis
BibTeX
@article{strachanowska2026physiotherapy,
title = {{Physiotherapy Interventions for Migraine: A Systematic Review of Clinical Trials.}},
author = {Helena Małgorzata Strachanowska and Martyna Anna Kaczmarska and Marlena Robakowska and Michał Brancewicz},
journal = {Clinics and practice},
year = {2026},
month = oct,
doi = {10.3390/clinpract16100192},
url = {https://europepmc.org/article/MED/42930377},
note = {CC BY},
}
RIS
TY - JOUR
TI - Physiotherapy Interventions for Migraine: A Systematic Review of Clinical Trials.
AU - Helena Małgorzata Strachanowska
AU - Martyna Anna Kaczmarska
AU - Marlena Robakowska
AU - Michał Brancewicz
PY - 2026
DA - 2026/10/13
JO - Clinics and practice
DO - 10.3390/clinpract16100192
UR - https://europepmc.org/article/MED/42930377
AB - Background: Migraine is one of the leading causes of disability worldwide and significantly reduces quality of life. Standard pharmacological treatment is often associated with adverse effects and does not always provide satisfactory long-term outcomes. Consequently, increasing attention has been directed toward non-pharmacological interventions such as physiotherapy. The aim of this systematic review was to evaluate the effectiveness of physiotherapy used as a standalone or complementary treatment for migraine. Methods: A systematic review of randomized controlled trials (RCTs) published between 2015 and 2025 was conducted in accordance with PRISMA 2020 guidelines. Electronic databases (PubMed, Cochrane Library, Scopus and PEDro) were searched using predefined search strategies. Studies involving adults diagnosed with migraine who received physiotherapy interventions (e.g., manual therapy, exercise therapy) were included. Two reviewers independently screened records and extracted data. Methodological quality of included studies was assessed using the PEDro scale. Results: Thirteen clinical trials (including 12 RCTs) involving 1021 participants were included. The most frequently investigated interventions were manual therapy and exercise therapy. Improvements in at least one primary clinical outcome (migraine frequency, pain intensity, or disability scores such as MIDAS or HIT-6) were observed in 8 out of 13 studies. A reduction in migraine frequency was reported in 4 studies. However, results were inconsistent across trials, and several studies found no statistically significant differences between the intervention and control groups. Conclusions: Physiotherapy may represent a beneficial complementary approach in migraine management, particularly for improving pain intensity and disability outcomes. However, the available evidence is limited by significant heterogeneity in intervention protocols, outcome measures, and follow-up duration, as well as the lack of quantitative synthesis. Further high-quality randomized trials with standardized methodology and longer follow-up periods are required to strengthen the evidence base.
SN - 2039-7275
SN - 2039-7283
ER -